960化工网
The structure-guided discovery of osimertinib: the first U.S. FDA approved mutant selective inhibitor of EGFR T790M†
Sam Butterworth,Darren A. E. Cross,M. Raymond V. Finlay,Richard A. Ward,Michael J. Waring
MedChemComm Pub Date : 05/10/2017 00:00:00 , DOI:10.1039/C7MD90012K
Abstract

A graphical abstract is available for this content

Graphical abstract: The structure-guided discovery of osimertinib: the first U.S. FDA approved mutant selective inhibitor of EGFR T790M
平台客服
平台客服
平台在线客服